Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos

Effectiveness of PSMA-Lutetium for Prostate Cancer Liver Metastases - Daniel Childs

January 13, 2025

Details

Online Platform Maps Theranostic Trials Worldwide for Patients and Physicians - Luke Nordquist

December 19, 2024

Details

Copper-67 (Cu-67 or 67Cu) in Cancer Therapy: Current Developments and Future Potential - Alan Taylor

July 31, 2024

Details

COBRA Trial: Evaluating 64Cu-SAR-bisPSMA PET Imaging for Prostate Cancer Detection - Phillip Koo

June 10, 2024

Details

Highlights: UCLA/UCSF Inaugural PSMA PET and RLT Conference - Jeremie Calais

January 30, 2024

Details

Nuclear Medicine Physician Discusses Career Path and Field Growth - Louise Emmett

November 20, 2023

Details

ENZA-p Trial Shows Promise for Enzalutamide-Lutetium Combination in Prostate Cancer - Louise Emmett

November 20, 2023

Details

The Evolution of PSMA Theranostics: A 30-Year Journey with the Prostate Cancer Foundation - Andrea Miyahira

November 2, 2023

Details

A Historical Perspective on Radioligand Therapy and Novel Treatment Modalities in the Management of mCRPC - Neil H. Bander

February 6, 2023

Details

PSMA PET Imaging Hot Topics - Neal Shore & Jason Efstathiou

November 4, 2022

Details

Imaging and PET Analysis as a Prognostic Tool for Lu-PSMA-617 Treatment in Patients with mCRPC - Phillip H. Kuo

October 16, 2022

Details

Clinical Trial Equity in Radionuclide Treatment for Prostate Cancer - Joseph Osborne

April 7, 2022

Details

Clinical Implementation of Pluvicto™ (177Lu-PSMA-617) - Michael Morris

April 3, 2022

Details

Pluvicto™ (177Lu-PSMA-617) Indications for Clinical Use in PSMA Positive Metastatic Castration-Resistant Prostate Cancer mCRPC - Oliver Sartor

March 28, 2022

Details

Pluvicto The First Targeted Radioligand Therapy for Treatment of Metastatic Castration-Resistant Prostate Cancer FDA Approved - Charles Ryan and Alicia Morgans

March 23, 2022

Details

Radiopharmaceuticals in Prostate Cancer: A Deep Dive into Patient-Reported Outcomes - Scott Tagawa

September 15, 2021

Details

The Upfront PSMA Study: Shifting Paradigms in Metastatic Hormone-Sensitive Disease - Declan Murphy & Arun Azad

July 1, 2021

Details

Lutetium-177 PSMA: A Closer Look at Its Therapeutic Potential and Side Effects - Bennett Chin

May 14, 2021

Details

Radionuclide Targeted Treatment in Progressing Metastatic Prostate Cancer - Michael Hofman

June 30, 2020

Details

PSMA-PET Imaging in Prostate Cancer & PSMA as a Therapeutic Target in Prostate Cancers - Thomas Hope and Johannas Czernin

June 30, 2020

Details

PSMA-directed Therapy - Scott Tagawa and Michael Morris

June 30, 2020

Details

PSMA Targeted Radiopharmaceuticals in Prostate Cancer: Pivotal Phase III VISION Trial - Oliver Sartor

June 30, 2020

Details

Precision Medicine: RadioIsotopes Targeted Therapies in Cancer - Stefano Fanti

June 30, 2020

Details

Academic and Community Practice Perspectives on Integrating PSMA Lutetium in the Clinic: Lessons Learned from Radium-223 Experience - Oliver Sartor and Nicholas Vogelzang

June 30, 2020

Details

Radiation Safety with Targeted Radionuclide Therapy - Thomas Hope

June 30, 2020

Details